ATLANTA, May 11, 2023 Femasys Inc. , a biomedical company aiming to meet women s needs by developing a suite of products and product candidates that include minimally invasive, in-office. | May 11, 2023
-Received regulatory approval for both FemaSeed® and FemCerv® products from Health Canada- ATLANTA, May 11, 2023 Femasys Inc. , a biomedical company aiming to meet women s needs. | May 11, 2023
- 2022 was a landmark year for women in the U.S. due to the overturn of Roe v. Wade which underscored the importance of potential reproductive health options
/PRNewswire/ Qvin™, the biotechnology company that developed the first and only healthcare service that scientifically collects menstrual blood to test for.